Antiviral Effect of Interferon Lambda Against Lymphocytic Choriomeningitis Virus

Journal of Interferon and Cytokine Research

Volumn 35, Issue 7, 2015, Pages 540-553

  Lukacikova, Lubomira ^a   Oveckova, Ingrid ^a   Betakova, Tatiana ^a   Laposova, Katarina ^a   Polcicova, Katarina ^a   Pastorekova, Silvia ^a   Pastorek, Jaromir ^a   Tomaskova, Jana ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RECOMBINANT INTERFERON; RECOMBINANT INTERFERON LAMBDA 2; RECOMBINANT INTERFERON LAMBDA 3; UNCLASSIFIED DRUG; ALPHA INTERFERON; ANTIVIRUS AGENT; GAMMA INTERFERON RECEPTOR; INTERFERON; INTERFERON RECEPTOR; PROTEIN SUBUNIT; STAT1 PROTEIN;

A549 CELL LINE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KINETICS; METABOLISM; PHOSPHORYLATION; PROTEIN SUBUNIT; VIROLOGY;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-ALPHA; INTERFERONS; KINETICS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN SUBUNITS; RECEPTORS, INTERFERON; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84937003575     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0083     Document Type: Article

References (77)

1. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180(4):2474-2485.
2. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80(9):4501-4509.
3. Barton LL, Mets MB. 1999. Lymphocytic choriomeningitis virus: pediatric pathogen and fetal teratogen. Pediatr Infect Dis J 18(6):540-541.
4. Barton LL, Mets MB, Beauchamp CL. 2002. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am J Obstet Gynecol 187(6):1715-1716.
5. Barton LL, Peters CJ, Ksiazek TG. 1995. Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen. Emerg Infect Dis 1(4):152-153.
6. Battegay M, Cooper S, Althage A, Banziger J, Hengartner H, Zinkernagel RM. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods 33(1-2):191-198.
7. Bergthaler A, Flatz L, Hegazy AN, Johnson S, Horvath E, Lohning M, Pinschewer DD. 2010. Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression. Proc Natl Acad Sci U S A 107(50):21641-21646.
8. Bevan MJ. 2004. Helping the CD8( + ) T-cell response. Nat Rev Immunol 4(8):595-602.
9. Borrow P, Martinez-Sobrido L, de la Torre JC. 2010. Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2(11):2443-2480.
10. Buchmeier MJ, de La Torre JC, Peters CJ. 2007. Arenaviridae: the viruses and their replication. In: Knipe DM, Howley, PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins, pp 1793-1826.
11. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MB. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 30:275-331.
12. Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S, Reith W, Ludewig B, Reizis B. 2012. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A 109(8):3012-3017.
13. de la Torre JC, Oldstone MB. 1996. Anatomy of viral persistence: mechanisms of persistence and associated disease. Adv Virus Res 46:311-343.
14. de Weerd NA, Nguyen T. 2012. The interferons and their receptors-distribution and regulation. Immunol Cell Biol 90(5):483-491.
15. Diegelmann J, Beigel F, Zitzmann K, Kaul A, Goke B, Auernhammer CJ, Bartenschlager R, Diepolder HM, Brand S. 2010. Comparative analysis of the lambda-interferons IL- 28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS One 5(12): e15200.
16. Djavani MM, Crasta OR, Zapata JC, Fei Z, Folkerts O, Sobral B, Swindells M, Bryant J, Davis H, Pauza CD, Lukashevich IS, Hammamieh R, Jett M, Salvato MS. 2007. Early blood profiles of virus infection in a monkey model for Lassa fever. J Virol 81(15):7960-7973.
17. Durbin RK, Kotenko SV, Durbin JE. 2013. Interferon induction and function at the mucosal surface. Immunol Rev 255(1): 25-39.
18. Evans JD, Crown RA, Sohn JA, Seeger C. 2011. West Nile virus infection induces depletion of IFNAR1 protein levels. Viral Immunol 24(4):253-263.
19. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, Comer JA, Guarner J, Paddock CD, DeMeo DL, Shieh WJ, Erickson BR, Bandy U, DeMaria A, Jr., Davis JP, Delmonico FL, Pavlin B, Likos A, Vincent MJ, Sealy TK, Goldsmith CS, Jernigan DB, Rollin PE, Packard MM, Patel M, Rowland C, Helfand RF, Nichol ST, Fishman JA, Ksiazek T, Zaki SR. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354(21):2235-2249.
20. Gibadulinova A, Zelnik V, Reiserova L, Zavodska E, Zatovicova M, Ciampor F, Pastorekova S, Pastorek J. 1998. Sequence and characterisation of the Z gene encoding ring finger protein of the lymphocytic choriomeningitis virus MX strain. Acta Virol 42(6):369-374.
21. Gronesova P, Mizakova A, Kabat P, Trnka A, Svetlikova D, Betakova T. 2007. Detection of influenza a virus in wild birds in West Slovakia by nested PCR. Acta Virol 51(1):63-65.
22. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4(11):3021-3024.
23. Hayes MW, Carrion R, Jr., Nunneley J, Medvedev AE, Salvato MS, Lukashevich IS. 2012. Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro. J Virol 86(13):7216-7226.
24. Hiscott J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev 18(5-6):483-490.
25. Hou W, Wang X, Ye L, Zhou L, Yang ZQ, Riedel E, Ho WZ. 2009. Lambda interferon inhibits human immunodeficiency virus type 1 infection ofmacrophages. J Virol 83(8):3834-3842.
26. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE. 2010. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84(21):11515-11522.
27. Kim PS, Ahmed R. 2010. Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 22(2):223-230.
28. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali- Krishna K. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202(5):637-650.
29. Kotenko SV. 2011. IFN-lambdas. Curr Opin Immunol 23(5): 583-590.
30. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4(1):69-77.
31. Kotenko SV, Langer JA. 2004. Full house: 12 receptors for 27 cytokines. Int Immunopharmacol 4(5):593-608.
32. Laposova K, Pastorekova S, Tomaskova J. 2013. Lymphocytic choriomeningitis virus: invisible but not innocent. Acta Virol 57(2):160-170.
33. Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, Ho W. 2011. Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia 59(1):58-67.
34. Lopusna K, Rezuchova I, Betakova T, Skovranova L, Tomaskova J, Lukacikova L, Kabat P. 2013. Interferons lambda, new cytokines with antiviral activity. Acta Virol 57(2):171-179.
35. Lukashevich IS, Rodas JD, Tikhonov, II, Zapata JC, Yang Y, Djavani M, Salvato MS. 2004. LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration. Arch Virol 149(12): 2319-2336.
36. Lukashevich IS, Tikhonov I, Rodas JD, Zapata JC, Yang Y, Djavani M, Salvato MS. 2003. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J Virol 77(3):1727-1737.
37. Ma D, Jiang D, Qing M, Weidner JM, Qu X, Guo H, Chang J, Gu B, Shi PY, Block TM, Guo JT. 2009. Antiviral effect of interferon lambda against West Nile virus. Antiviral Res 83(1):53-60.
38. Malmgaard L, Salazar-Mather TP, Lewis CA, Biron CA. 2002. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways. J Virol 76(9):4520-4525.
39. Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, Pellegrini S. 2006. TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem J 397(1):31-38.
40. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80(18):9192-9199.
41. Merigan TC, Oldstone MB, Welsh RM. 1977. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 268(5615):67-68.
42. Mets MB, Barton LL, Khan AS, Ksiazek TG. 2000. Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am J Ophthalmol 130(2):209-215.
43. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4(9):e1000151.
44. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V, Sorgeloos F, Ehl S, Mayer D, Kochs G, Schwemmle M, Gunther S, Drosten C, Michiels T, Staeheli P. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84(11):5670-5677.
45. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264(5167): 1918-1921.
46. Odorizzi PM, Wherry EJ. 2013. Immunology. An interferon paradox. Science 340(6129):155-156.
47. Oldstone MB. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol 263:83-117.
48. Oldstone MB. 2009. Anatomy of viral persistence. PLoS Pathog 5(7):e1000523.
49. Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, Namiki H, Fujita T. 2007. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282(10):7576-7581.
50. Ou R, Zhou S, Huang L, Moskophidis D. 2001. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol 75(18):8407-8423.
51. Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD. 2010. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 401(2):197-206.
52. Pagliaccetti NE, Eduardo R, Kleinstein SH, Mu XJ, Bandi P, Robek MD. 2008. Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J Biol Chem 283(44):30079-30089.
53. Pagliaccetti NE, Robek MD. 2010. Interferon-lambda in HCV infection and therapy. Viruses 2(8):1589-1602.
54. Palacios G, Druce J, Du L, Tran T, Birch C, Briese T, Conlan S, Quan PL, Hui J, Marshall J, Simons JF, Egholm M, Paddock CD, Shieh WJ, Goldsmith CS, Zaki SR, Catton M, Lipkin WI. 2008. A new arenavirus in a cluster of fatal transplantassociated diseases. N Engl J Med 358(10):991-998.
55. Pestka S, Krause CD, Walter MR. 2004. Interferons, interferonlike cytokines, and their receptors. Immunol Rev 202:8-32.
56. Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, Staeheli P, Hornef MW. 2011. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108(19):7944-7949.
57. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, OBrien TR. 2013. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45(2):164-171.
58. Pythoud C, Rodrigo WW, Pasqual G, Rothenberger S, Martinez- Sobrido L, de la Torre JC, Kunz S. 2012. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKK{varepsilon}. J Virol 86(15):7728-7738.
59. Qian J, Zheng H, Huangfu WC, Liu J, Carbone CJ, Leu NA, Baker DP, Fuchs SY. 2011. Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1. PLoS Pathog 7(6):e1002065.
60. Quandt K, Frech K, Karas H, Wingender E, Werner T. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23(23):4878-4884.
61. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89(Pt 1):1-47.
62. Reiserova L, Kaluzova M, Kaluz S, Willis AC, Zavada J, Zavodska E, Zavadova Z, Ciampor F, Pastorek J, Pastorekova S. 1999. Identification of MaTu-MX agent as a new strain of lymphocytic choriomeningitis virus (LCMV) and serological indication of horizontal spread of LCMV in human population. Virology 257(1):73-83.
63. Robek MD, Boyd BS, Chisari FV. 2005. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79(6): 3851-3854.
64. Rodrigo WW, Ortiz-Riano E, Pythoud C, Kunz S, de la Torre JC, Martinez-Sobrido L. 2012. Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol 86(15): 8185-8197.
65. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8(7):559-568.
66. Salvato M, Borrow P, Shimomaye E, Oldstone MB. 1991. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol 65(4):1863-1869.
67. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. 2003. IL-28, IL-29 and their class II cytokine receptor IL- 28R. Nat Immunol 4(1):63-68.
68. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFNlambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4(3):e1000017.
69. Svetlikova D, Kabat P, Ohradanova A, Pastorek J, Betakova T. 2010. Influenza A virus replication is inhibited in IFNlambda2 and IFN-lambda3 transfected or stimulated cells. Antiviral Res 88(3):329-333.
70. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340(6129):207-211.
71. Tomaskova J, Labudova M, Kopacek J, Pastorekova S, Pastorek J. 2008. Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX. Virus Genes 37(1):31-38.
72. Tomaskova J, Oveckova I, Labudova M, Lukacikova L, Laposova K, Kopacek J, Pastorekova S, Pastorek J. 2011. Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus. J Virol 85(24): 13069-13076.
73. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, Aronow BJ, Karp CL, Brooks DG. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340(6129):202-207.
74. Zhang D, Zhang DE. 2011. Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon Cytokine Res 31(1):119-130.
75. Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, Finberg RW. 2010. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol 84(18):9452-9462.
76. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. 2007. Type III interferon (IFN) induces a type I IFNlike response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen- activated protein kinases. J Virol 81(14):7749-7758.
77. Zinkernagel RM. 2002. Lymphocytic choriomeningitis virus and immunology. Curr Top Microbiol Immunol 263:1-5.